By otakuyassine3@gmail.com 
Everett Harris & Co. CA cut its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 0.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 783,904 shares of the company’s stock after selling 2,691 shares during the period. Colgate-Palmolive comprises approximately 0.9% of Everett Harris & Co. CA’s investment portfolio, making the stock its 25th biggest holding. Everett Harris & Co. CA owned approximately 0.10% of Colgate-Palmolive worth $71,265,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive in the 4th quarter valued at $32,000. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the third quarter worth about $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the 3rd quarter valued at about $53,000. Synergy Asset Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $49,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $64,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on CL shares. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Stifel Nicolaus dropped their price target on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $102.00.
Get Our Latest Research Report on Colgate-Palmolive
Insider Buying and Selling
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.34% of the stock is currently owned by insiders.
Colgate-Palmolive Stock Down 4.7 %
CL stock opened at $86.64 on Friday. The stock has a market cap of $70.78 billion, a P/E ratio of 24.82, a P/E/G ratio of 3.70 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock’s fifty day simple moving average is $91.52 and its two-hundred day simple moving average is $97.25. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.27% and a return on equity of 405.81%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. Analysts expect that Colgate-Palmolive will post 3.58 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. Colgate-Palmolive’s payout ratio is 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Receive News & Ratings for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.